Desmin is a 53.5 kD protein composed of 470 amino acids. There are three major domains to the desmin protein: a conserved alpha helix rod, a variable non alpha helix head, and a carboxy-terminal tail. Desmin, as all intermediate filaments, shows no polarity when assembled. The rod domain consists of 308 amino acids with parallel alpha helical coiled coil dimers and three linkers to disrupt it. The rod domain connects to the head domain. The head domain 84 amino acids with many arginine, serine, and aromatic residues is important in filament assembly and dimer-dimer interactions. The tail domain is responsible for the integration of filaments and interaction with proteins and organelles. Desmin is only expressed in vertebrates, however homologous proteins are found in many organisms. Desmin is a subunit of intermediate filaments in cardiac muscle, skeletal muscle and smooth muscle tissue. In cardiac muscle, desmin is present in Z-discs and intercalated discs. Desmin has been shown to interact with desmoplakin and αB-crystallin.
Desmin was first described in 1976, first purified in 1977, the gene was cloned in 1989, and the first knockout mouse was created in 1996. The function of desmin has been deduced through studies in knockout mice. Desmin is one of the earliest protein markers for muscle tissue in embryogenesis as it is detected in the somites. Although it is present early in the development of muscle cells, it is only expressed at low levels, and increases as the cell nears terminal differentiation. A similar protein, vimentin, is present in higher amounts during embryogenesis while desmin is present in higher amounts after differentiation. This suggests that there may be some interaction between the two in determining muscle cell differentiation. However desmin knockout mice develop normally and only experience defects later in life. Since desmin is expressed at a low level during differentiation another protein may be able to compensate for desmin's function early in development but not later on.
In adult desmin-null mice, hearts from 10 wk-old animals showed drastic alterations in muscle architecture, including a misalignment of myofibrils and disorganization and swelling of mitochondria; findings that were more severe in cardiac relative to skeletal muscle. Cardiac tissue also exhibited progressive necrosis and calcification of the myocardium. A separate study examined this in more detail in cardiac tissue and found that murine hearts lacking desmin developed hypertrophic cardiomyopathy and chamber dilation combined with systolic dysfunction. In adult muscle, desmin forms a scaffold around the Z-disk of the sarcomere and connects the Z-disk to the subsarcolemmal cytoskeleton. It links the myofibrils laterally by connecting the Z-disks. Through its connection to the sarcomere, desmin connects the contractile apparatus to the cell nucleus, mitochondria, and post-synaptic areas of motor endplates. These connections maintain the structural and mechanical integrity of the cell during contraction while also helping in force transmission and longitudinal load bearing. In human heart failure, desmin expression is upregulated, which has been hyopthesized to be a defense mechanism in an attempt to maintain normal sarcomere alignment amidst disease pathogenesis. There is some evidence that desmin may also connect the sarcomere to the extracellular matrix (ECM) through desmosomes which could be important in signalling between the ECM and the sarcomere which could regulate muscle contraction and movement. Finally, desmin may be important in mitochondria function. When desmin is not functioning properly there is improper mitochondrial distribution, number, morphology and function. Since desmin links the mitochondria to the sarcomere it may transmit information about contractions and energy need and through this regulate the aerobic respiration rate of the muscle cell.
Desmin-related myofibrillar myopathy (DRM or Desminopathy) is a subgroup of the myofibrillar myopathy diseases and is the result of a mutation in the gene that codes for desmin which prevents it from forming protein filaments, and rather, forms aggregates of desmin and other proteins throughout the cell. Desmin mutations have been associated with restrictive and idopathic cardiomyopathy.; and recently, mutations were identified in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). Some of these DES mutations like p.N116S or p.E114del cause an aggregation of desmin within the cytoplasm. A mutation p.A120D was discovered in a family where several members had sudden cardiac death.
Desmin has been evaluated for role in assessing the depth of invasion of urothelial carcinoma in TURBT specimens.
^Sequeira V, Nijenkamp LL, Regan JA, van der Velden J (Feb 2014). "The physiological role of cardiac cytoskeleton and its alterations in heart failure". Biochimica Et Biophysica Acta1838 (2): 700–22. doi:10.1016/j.bbamem.2013.07.011. PMID23860255.
^ abcdefghiBär H, Strelkov SV, Sjöberg G, Aebi U, Herrmann H (November 2004). "The biology of desmin filaments: how do mutations affect their structure, assembly, and organisation?". J. Struct. Biol.148 (2): 137–52. doi:10.1016/j.jsb.2004.04.003. PMID15477095.
^Meng JJ, Bornslaeger EA, Green KJ, Steinert PM, Ip W (August 1997). "Two-hybrid analysis reveals fundamental differences in direct interactions between desmoplakin and cell type-specific intermediate filaments". J. Biol. Chem.272 (34): 21495–503. doi:10.1074/jbc.272.34.21495. PMID9261168.
^Bennardini F, Wrzosek A, Chiesi M (Aug 1992). "Alpha B-crystallin in cardiac tissue. Association with actin and desmin filaments". Circulation Research71 (2): 288–94. doi:10.1161/01.res.71.2.288. PMID1628387.
^Costa ML, Escaleira R, Cataldo A, Oliveira F, Mermelstein CS (December 2004). "Desmin: molecular interactions and putative functions of the muscle intermediate filament protein". Braz. J. Med. Biol. Res.37 (12): 1819–30. doi:10.1590/S0100-879X2004001200007. PMID15558188.
^Stoeckert C (1997-03-16). "Dystrophin". Catalogue of Regulatory Elements. University of Pennsylvania. Retrieved 2010-06-28.
^Milner DJ, Weitzer G, Tran D, Bradley A, Capetanaki Y (Sep 1996). "Disruption of muscle architecture and myocardial degeneration in mice lacking desmin". The Journal of Cell Biology134 (5): 1255–70. doi:10.1083/jcb.134.5.1255. PMID8794866.
^Milner DJ, Taffet GE, Wang X, Pham T, Tamura T, Hartley C, Gerdes AM, Capetanaki Y (Nov 1999). "The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function". Journal of Molecular and Cellular Cardiology31 (11): 2063–76. doi:10.1006/jmcc.1999.1037. PMID10591032.
^ abPaulin D, Li Z (November 2004). "Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle". Exp. Cell Res.301 (1): 1–7. doi:10.1016/j.yexcr.2004.08.004. PMID15501438.
^Heling A, Zimmermann R, Kostin S, Maeno Y, Hein S, Devaux B, Bauer E, Klövekorn WP, Schlepper M, Schaper W, Schaper J (Apr 2000). "Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium". Circulation Research86 (8): 846–53. doi:10.1161/01.res.86.8.846. PMID10785506.
^Milner DJ, Mavroidis M, Weisleder N, Capetanaki Y (2000). "Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function.". Journal of Cell Biology150: 1283–1298. doi:10.1083/jcb.150.6.1283.
^Li D, Tapscoft T, Gonzalez O, Burch PE, Quiñones MA, Zoghbi WA, Hill R, Bachinski LL, Mann DL, Roberts R (Aug 1999). "Desmin mutation responsible for idiopathic dilated cardiomyopathy". Circulation100 (5): 461–4. doi:10.1161/01.cir.100.5.461. PMID10430757.
^Goldfarb LG, Park KY, Cervenáková L, Gorokhova S, Lee HS, Vasconcelos O, Nagle JW, Semino-Mora C, Sivakumar K, Dalakas MC (Aug 1998). "Missense mutations in desmin associated with familial cardiac and skeletal myopathy". Nature Genetics19 (4): 402–3. doi:10.1038/1300. PMID9697706.
^Klauke B, Kossmann S, Gaertner A, Brand K, Stork I, Brodehl A, Dieding M, Walhorn V, Anselmetti D, Gerdes D, Bohms B, Schulz U, Zu Knyphausen E, Vorgerd M, Gummert J, Milting H (2010). "De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy". Hum. Mol. Genet.19 (23): 4595–607. doi:10.1093/hmg/ddq387. PMID20829228.
^Lorenzon A, Beffagna G, Bauce B, De Bortoli M, Li Mura IE, Calore M, Dazzo E, Basso C, Nava A, Thiene G, Rampazzo A (Feb 2013). "Desmin mutations and arrhythmogenic right ventricular cardiomyopathy". The American Journal of Cardiology111 (3): 400–5. doi:10.1016/j.amjcard.2012.10.017. PMID23168288.
^Brodehl A, Dieding M, Klauke B, Dec E, Madaan S, Huang T, Gargus J, Fatima A, Saric T, Cakar H, Walhorn V, Tönsing K, Skrzipczyk T, Cebulla R, Gerdes D, Schulz U, Gummert J, Svendsen JH, Olesen MS, Anselmetti D, Christensen AH, Kimonis V, Milting H (2013). "The novel desmin mutant p.A120D impairs filament formation, prevents intercalated disk localization, and causes sudden cardiac death". Circ Cardiovasc Genet6 (6): 615–23. doi:10.1161/CIRCGENETICS.113.000103. PMID24200904.
^Saha K, Saha A, Datta C, Chatterjee U, Ray S, Bera M. Does desmin immunohistochemistry have a role in assessing stage of urothelial carcinoma in transurethral resection of bladder tumor specimens? Clin Cancer Investig J 2014;3(6):502-7.DOI: 10.4103/2278-0513.142634